Terms: = Thyroid cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Prognosis
206 results:
1. Papillary thyroid carcinoma tall cell subtype (PTC-TC) and high-grade differentiated thyroid carcinoma tall cell phenotype (HGDTC-TC) have different clinical behaviour: a retrospective study of 1456 patients.
Ghossein R; Katabi N; Dogan S; Shaha AR; Tuttle RM; Fagin JA; Ganly I; Xu B
Histopathology; 2024 Jun; 84(7):1130-1138. PubMed ID: 38528726
[TBL] [Abstract] [Full Text] [Related]
2. Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis.
Gharzai LA; Morris E; Suresh K; Nguyen-Tân PF; Rosenthal DI; Gillison ML; Harari PM; Garden AS; Koyfman S; Caudell JJ; Jones CU; Mitchell DL; Krempl G; Ridge JA; Gensheimer MF; Bonner JA; Filion E; Dunlap NE; Stokes WA; Le QT; Torres-Saavedra P; Mierzwa M; Schipper MJ
Lancet Oncol; 2024 Mar; 25(3):366-375. PubMed ID: 38423050
[TBL] [Abstract] [Full Text] [Related]
3. Measuring discrepancies between simple medullary and synchronous medullary/papillary thyroid carcinomas: a comparative cross-sectional study.
Zhang D; Yang M; Frattini F; Cestari A; Li K; Wang H; Chi H; Sui C; Bai K; Lan D; Dionigi G; Sun H
Front Endocrinol (Lausanne); 2023; 14():1301200. PubMed ID: 38317715
[TBL] [Abstract] [Full Text] [Related]
4. A novel nomogram and recursive partitioning analysis for predicting cancer-specific survival of patients with subcutaneous leiomyosarcoma.
Ji Q; Hu H; Li S; Tang J
Sci Rep; 2024 Feb; 14(1):2861. PubMed ID: 38311615
[TBL] [Abstract] [Full Text] [Related]
5. Adrenal incidentalomas, cortisol secretion and cancer: is there a real crosstalk?
Herrera-Martínez AD; Román ÁR; Corrales EP; Idrobo C; Ramírez PP; Rojas PM; Lázaro CR; Araujo-Castro M
Front Endocrinol (Lausanne); 2023; 14():1335202. PubMed ID: 38264281
[TBL] [Abstract] [Full Text] [Related]
6. Metastasis, characteristic, and treatment of breast cancer in young women and older women: A study from the Surveillance, Epidemiology, and End Results registration database.
Gao X; Zhang F; Zhou Q; Xu H; Bian J
PLoS One; 2023; 18(11):e0293830. PubMed ID: 37917616
[TBL] [Abstract] [Full Text] [Related]
7. Preoperative tracheostomy is associated with thyroid gland invasion and poorer prognosis in laryngectomized patients.
Noy R; Habashi N; Akrish S; Cohen J; Shkedy Y
Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):935-943. PubMed ID: 37880425
[TBL] [Abstract] [Full Text] [Related]
8. Predictive risk factors for distant metastasis in pediatric differentiated thyroid cancer from Saudi Arabia.
Parvathareddy SK; Siraj AK; Annaiyappanaidu P; Siraj N; Al-Rasheed M; Al-Haqawi W; Qadri Z; Siddiqui K; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
Front Endocrinol (Lausanne); 2023; 14():1228049. PubMed ID: 37867506
[TBL] [Abstract] [Full Text] [Related]
9. Risk factors for cervical lymph node metastasis in the central or lateral cervical region in medullary thyroid carcinoma: a systematic review and meta-analysis.
Lin X; Huo J; Su H; Zhu C; Xu Y; Zhang F
Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):547-561. PubMed ID: 37801162
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological features and prognostic value of CD276 expression in head and neck cancer: A meta-analysis.
Su H; Li N; Chen Z; Hao J; Zhang F
Am J Otolaryngol; 2023; 44(6):103968. PubMed ID: 37442085
[TBL] [Abstract] [Full Text] [Related]
11. Recurrence-free survival and prognosis after adjuvant therapy with radioactive iodine-131 in patients with differentiated thyroid carcinoma.
Iizuka Y; Katagiri T; Ogura K; Inoue M; Nakashima R; Nakamura K; Mizowaki T
Sci Rep; 2023 Jul; 13(1):10795. PubMed ID: 37402838
[TBL] [Abstract] [Full Text] [Related]
12. [Correlation Analysis between thyroid Function Abnormality and Efficacy in Patients
with Advanced Non-small Cell Lung cancer after Immunotherapy].
Wang Y; Wang X; Cheng L; Zhang G
Zhongguo Fei Ai Za Zhi; 2023 May; 26(5):369-376. PubMed ID: 37316446
[TBL] [Abstract] [Full Text] [Related]
13. The effect of central lymph node dissection on the prognosis of cN0 papillary thyroid microcarcinoma: a mid-term follow-up study.
Xie X; Deng J; Zheng B; Zhong L; Miao J
BMC Endocr Disord; 2023 May; 23(1):125. PubMed ID: 37248461
[TBL] [Abstract] [Full Text] [Related]
14. A multi-institutional retrospective study of 340 cases of sinonasal malignant tumor.
Tsuji T; Asato R; Kada S; Kitamura M; Tamaki H; Mizuta M; Tanaka S; Watanabe Y; Hori R; Kojima T; Shinohara S; Takebayashi S; Maetani T; Harada H; Kitani Y; Kumabe Y; Tsujimura T; Honda K; Ichimaru K; Ushiro K; Omori K
Auris Nasus Larynx; 2024 Feb; 51(1):86-98. PubMed ID: 37248104
[TBL] [Abstract] [Full Text] [Related]
15. The SINTART 1 study. A phase II non-randomised controlled trial of induction chemotherapy, surgery, photon-, proton- and carbon ion-based radiotherapy integration in patients with locally advanced resectable sinonasal tumours.
Resteghini C; Castelnuovo P; Nicolai P; Orlandi E; Bossi P; Vischioni B; Schreiber A; Gambazza S; Iacovelli NA; Battaglia P; Guzzo M; Turri-Zanoni M; Mattavelli D; Facchinetti N; Calareso G; Ravanelli M; Facco C; Tartaro T; Licitra L
Eur J Cancer; 2023 Jul; 187():185-194. PubMed ID: 37164774
[TBL] [Abstract] [Full Text] [Related]
16. Log odds of negative lymph nodes/T stage ratio (LONT): A new prognostic tool for differentiated thyroid cancer without metastases in patients aged 55 and older.
Wang X; Wu Y; Li X; Hong J; Zhang M
Front Endocrinol (Lausanne); 2023; 14():1132687. PubMed ID: 37033269
[TBL] [Abstract] [Full Text] [Related]
17. Incorporation size of lymph node metastasis focus and pre-ablation stimulated Tg could more effectively predict clinical outcomes in differentiated thyroid cancer patients without distant metastases.
Xie J; Chen P; Wang J; Luo X; Luo J; Xiong X; Li C; Pan L; Wu J; Feng H; Ouyang W
Front Endocrinol (Lausanne); 2023; 14():1094339. PubMed ID: 37025409
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic disparities in young patients based on breast cancer subtype: A population-based study from the SEER database.
Chen B; Zhang X; Liu Y; Wang C
Medicine (Baltimore); 2023 Mar; 102(13):e33416. PubMed ID: 37000095
[TBL] [Abstract] [Full Text] [Related]
19. Circ0005654 as a new biomarker of thyroid cancer interacting with SP1 to influence the prognosis: A case-control study.
Yang C; Cao ZG; Zhou ZW; Han SJ
Medicine (Baltimore); 2023 Feb; 102(6):e32853. PubMed ID: 36820560
[TBL] [Abstract] [Full Text] [Related]
20. Peptide Receptor Radionuclide Therapy in Patients With Advanced Progressive Medullary thyroid cancer: Efficacy, Safety, and Survival Predictors.
Liu Q; Kulkarni HR; Zhao T; Schuchardt C; Chen X; Zhu Z; Zhang J; Baum RP
Clin Nucl Med; 2023 Mar; 48(3):221-227. PubMed ID: 36723881
[TBL] [Abstract] [Full Text] [Related]
[Next]
